This is a preview of subscription content, log in via an institution to check access.
Data Availability
Not applicable.
References
Durandy A, Kracker S. Class switch recombination defects. In: Sullivan KE, Stiehm ER, editors. Stiehm’s Immune Deficiencies: Inborn Errors in Immunity. 2nd ed. Cambridge, MA: Academic Press; 2020. p. 499–517.
Al-Saud BK, Al-Sum Z, Alassiri H, Al-Ghonaium A, Al-Muhsen S, Al-Dhekri H, Arnaout R, Alsmadi O, Borrero E, Abu-Staiteh A, Rawas F, Al-Mousa H, Hawwari A. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol. 2013;33(8):1325–35. https://doi.org/10.1007/s10875-013-9951-9.
Al-Saud B, Al-Jomaie M, Al-Ghonaium A, Al-Ahmari A, Al-Mousa H, Al-Muhsen S, Al-Seraihy A, Arnaout R, Elshorbagi S, Al-Dhekri H, Ayas M. Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience. Bone Marrow Transplant. 2019;54(1):63–7. https://doi.org/10.1038/s41409-018-0219-0.
Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, Giliani S, Notarangelo LD, Kutukculer N. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplant. 2007;40(3):279–81. https://doi.org/10.1038/sj.bmt.1705713.
Al-Dhekri H, Al-Sum Z, Al-Saud B, Al-Mousa H, Ayas M, Al-Muhsen S, Arnaout R, Al-Seraihy A, Hawwari A, Al-Ghonaium A. Successful outcome in two patients with CD40 deficiency treated with allogeneic HCST. Clin Immunol. 2012;143(1):96–8. https://doi.org/10.1016/j.clim.2012.01.012.
Funding
Funding for this research was provided by the Jeffrey Modell Diagnostic Center, affiliated with Cohen Children’s Medical Center and the Feinstein Institutes for Medical Research.
Author information
Authors and Affiliations
Contributions
All authors contributed to the development and conceptualization of this case report. The patient evaluation, data collection, and clinical interpretation were conducted by Sultan Majid, Nikki Kimura, and Vincent Bonagura. Flow cytometry studies were performed by Fung Lam. The initial draft of the report was composed by Sultan Majid, with every author offering feedback on its subsequent versions. All authors have reviewed and approved the final version of the case report.
Corresponding author
Ethics declarations
Ethics Approval
This case report, focusing on fewer than three patients, is not deemed human-subject research as per the Feinstein Institute for Medical Research Human Research Protection Program Guidance. Consequently, Institutional Review Board (IRB) approval is not necessitated for its publication. All associated data has been handled in compliance with HIPAA regulations, ensuring patient confidentiality and protection of identifiers.
Consent to Participate
Not applicable.
Consent for Publication
Written informed consent was obtained from both parents.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Majid, S., Kimura, N., Lam, F. et al. Compound Heterozygosity in Hyper‑IgM Syndrome Type 3: Case Report and Literature Review. J Clin Immunol 44, 64 (2024). https://doi.org/10.1007/s10875-024-01666-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10875-024-01666-0